Skeletal Muscle. Ca2+ release control inside the SR

骨骼肌。

基本信息

  • 批准号:
    7093516
  • 负责人:
  • 金额:
    $ 30.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-07-01 至 2008-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Ca2+ signaling links plasma membrane events to metabolic change. Excitation-contraction (EC) coupling -- which in muscle transduces the action potential to increase in intracellular Ca2+ concentration, and contraction-- was the first recognized example of Ca2+ signaling. Its key molecules (voltage sensors or DHPrs and release channels or RyRs) are increasingly found in other cells and tissues. Its involvement is recognized in an increasing number of inheritable diseases. Its changes, upon prolonged exercise, crucially contribute to muscle fatigue. EC coupling has traditionally been probed by measuring Ca2+ transients, based on the consensus that control of Ca2+ release is exerted by ligands (like Ca2+, or loops in the DHPr) at the cytosolic face of the RyRs. Evidence is now increasing for crucial regulation from within the SR. This is a proposal for the systematic study of such control. Four working hypotheses will be tested, which elaborate the idea of regulation from within the SR: 1) Ca2+ release activation is largely determined by SR Ca2+ content. 2) Ca2+ release termination is largely determined by local Ca2+ depletion within the SR. 3) A novel concerted mode of channel activation is controlled by SR Ca. 4) The intra-SR Ca2+-binding protein calsequestrin has a dynamic role in regulation of Ca2+ release, which may involve interactions with other SR proteins. These hypotheses will be tested by 1) monitoring Ca2+ release on single cells, at the cell-averaged and at the local level (where it results in Ca2+ sparks), while manipulating and monitoring the Ca2+ content of the SR. 2) Introducing extrinsic Ca2+ buffers in the SR, one of which, sulfate, has already proved to have extraordinary effects. 3) Changing the concentration and functionality of calsequestrin, by its over- or under-expression in cells in culture, or by gene transfer to adult muscle. 4) To better understand molecular requirements, effects of calsequestrin will be sought on the control of single RyRs by Ca2+. 5) An existing model of Ca2+ release will help test the validity of various quantitative versions of these hypotheses. Technical innovation is substantial in aims 1 (simultaneous recording of intra-SR and cytosolic [Ca2+]), 2 (distinction of buffers and limit-buffers), 3 (transfer of calsequestrin genes to adult muscle) and 4 (combined application of calsequestrin and photoreleased Ca to channels in bilayers).
描述(由申请人提供):Ca 2+信号转导将质膜事件与代谢变化联系起来。兴奋-收缩(EC)偶联-在肌肉中转导动作电位以增加细胞内Ca 2+浓度和收缩-是Ca 2+信号传导的第一个公认的例子。它的关键分子(电压传感器或DHPrs和释放通道或RyR)越来越多地在其他细胞和组织中发现。越来越多的遗传性疾病都与此有关。它的变化,在长时间的运动,至关重要的是有助于肌肉疲劳。EC偶联传统上通过测量Ca 2+瞬变来探测,基于这样的共识,即Ca 2+释放的控制是由RyR的胞质面处的配体(如Ca 2+或DHPr中的环)施加的。现在越来越多的证据表明,关键的监管从内部SR。这是一个系统的研究这种控制的建议。将测试四个工作假设,其阐述了SR内调节的想法:1)Ca 2+释放激活主要由SR Ca 2+含量决定。2)钙释放的终止主要取决于SR内的局部Ca ~(2+)耗尽。3)SR Ca ~(2+)控制一种新的协同通道激活模式。4)SR内钙结合蛋白calsequestrin在调节钙释放中具有动态作用,这可能涉及与其他SR蛋白的相互作用。这些假设将通过以下方式进行测试:1)在细胞平均水平和局部水平(其导致Ca 2+火花)监测单个细胞上的Ca 2+释放,同时操纵和监测SR的Ca 2+含量。2)在SR中引入外源性Ca 2+缓冲液,其中之一硫酸盐已被证明具有非凡的效果。3)改变钙螯合蛋白的浓度和功能,通过其在培养的细胞中的过度表达或表达不足,或通过基因转移到成人肌肉。4)为了更好地理解分子的要求,将寻求钙螯合蛋白对Ca 2+控制单个RyR的影响。 5)现有的Ca 2+释放模型将有助于测试这些假设的各种定量版本的有效性。技术创新在目标1(同时记录SR内和胞质[Ca 2 +])、2(缓冲液和限制缓冲液的区别)、3(将钙螯合蛋白基因转移到成人肌肉)和4(将钙螯合蛋白和光释放的Ca结合应用于双层通道)中具有实质性意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eduardo Rios其他文献

Eduardo Rios的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eduardo Rios', 18)}}的其他基金

Dual Confocal Microscopic Scanner
双共焦显微扫描仪
  • 批准号:
    7389185
  • 财政年份:
    2008
  • 资助金额:
    $ 30.16万
  • 项目类别:
Skeletal Muscle. Ca Release Control Inside the Sarcoplasmic Reticulum.
骨骼肌。
  • 批准号:
    8268539
  • 财政年份:
    2003
  • 资助金额:
    $ 30.16万
  • 项目类别:
Skeletal Muscle. Ca2+ release control inside the SR
骨骼肌。
  • 批准号:
    6678047
  • 财政年份:
    2003
  • 资助金额:
    $ 30.16万
  • 项目类别:
Skeletal Muscle. Ca2+ release control inside the SR
骨骼肌。
  • 批准号:
    7256325
  • 财政年份:
    2003
  • 资助金额:
    $ 30.16万
  • 项目类别:
Skeletal Muscle. Ca Release Control Inside the Sarcoplasmic Reticulum.
骨骼肌。
  • 批准号:
    7800322
  • 财政年份:
    2003
  • 资助金额:
    $ 30.16万
  • 项目类别:
Skeletal Muscle. Ca2+ release control inside the SR
骨骼肌。
  • 批准号:
    6915217
  • 财政年份:
    2003
  • 资助金额:
    $ 30.16万
  • 项目类别:
Skeletal Muscle. Ca2+ release control inside the SR
骨骼肌。
  • 批准号:
    6761791
  • 财政年份:
    2003
  • 资助金额:
    $ 30.16万
  • 项目类别:
Skeletal Muscle. Ca Release Control Inside the Sarcoplasmic Reticulum.
骨骼肌。
  • 批准号:
    8067962
  • 财政年份:
    2003
  • 资助金额:
    $ 30.16万
  • 项目类别:
Skeletal Muscle. Ca Release Control Inside the Sarcoplasmic Reticulum.
骨骼肌。
  • 批准号:
    8464002
  • 财政年份:
    2003
  • 资助金额:
    $ 30.16万
  • 项目类别:
Skeletal Muscle. Ca Release Control Inside the Sarcoplasmic Reticulum.
骨骼肌。
  • 批准号:
    7650759
  • 财政年份:
    2003
  • 资助金额:
    $ 30.16万
  • 项目类别:

相似海外基金

DNAzymes for Site-Specific DNA and RNA Nucleobase Modification
用于位点特异性 DNA 和 RNA 核碱基修饰的 DNAzyme
  • 批准号:
    10630686
  • 财政年份:
    2023
  • 资助金额:
    $ 30.16万
  • 项目类别:
Molecular mechanisms underlying heme transport at the blood-brain barrier and its role in angiogenesis
血红素在血脑屏障转运的分子机制及其在血管生成中的作用
  • 批准号:
    10572752
  • 财政年份:
    2023
  • 资助金额:
    $ 30.16万
  • 项目类别:
Mechanism of nuclear pore passage of the HIV-1 capsid
HIV-1衣壳核孔通过机制
  • 批准号:
    10762097
  • 财政年份:
    2023
  • 资助金额:
    $ 30.16万
  • 项目类别:
Revealing mechanisms of specificity and adaptability in molecular information processing through data-driven models
通过数据驱动模型揭示分子信息处理的特异性和适应性机制
  • 批准号:
    10715575
  • 财政年份:
    2023
  • 资助金额:
    $ 30.16万
  • 项目类别:
Alpha-Synuclein aberrantly modifies the nanoscale distribution and function of ion channels to promote neuronal cytotoxicity
α-突触核蛋白异常地改变离子通道的纳米级分布和功能以促进神经元细胞毒性
  • 批准号:
    10635208
  • 财政年份:
    2023
  • 资助金额:
    $ 30.16万
  • 项目类别:
High-throughput high-resolution microscopy for phenotypic drug discovery applications
用于表型药物发现应用的高通量高分辨率显微镜
  • 批准号:
    10654145
  • 财政年份:
    2023
  • 资助金额:
    $ 30.16万
  • 项目类别:
Probing how hair bundle mechanical properties shape the mechanotransducer receptor current
探讨发束机械特性如何塑造机械传感器受体电流
  • 批准号:
    10778103
  • 财政年份:
    2023
  • 资助金额:
    $ 30.16万
  • 项目类别:
Mitochondrial proton leak and neonatal brain injury
线粒体质子泄漏与新生儿脑损伤
  • 批准号:
    10724518
  • 财政年份:
    2023
  • 资助金额:
    $ 30.16万
  • 项目类别:
Investigating the role of lipid membrane in the cochlear hair cell mechanotransduction
研究脂质膜在耳蜗毛细胞机械转导中的作用
  • 批准号:
    10652895
  • 财政年份:
    2023
  • 资助金额:
    $ 30.16万
  • 项目类别:
Development of Optofluidic Resonators for Filoviral Detection
用于丝状病毒检测的光流控谐振器的开发
  • 批准号:
    10506889
  • 财政年份:
    2022
  • 资助金额:
    $ 30.16万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了